They suggest that tumor-infiltrating M1 (CD86+) and M2 (CSF1-R+) macrophages have a peri-T location and that more macrophages (CD68+) than DLBCL cells (CD20+) express these two markers. Here, CD86 is linked to diffuse large B-cell lymphoma.